Skip to Main content Skip to Navigation
Journal articles

Evaluation of the versatile character of a nanoemulsion formulation

Abstract : The formulate-ability of six model active pharmaceutical ingredients (API), with different physico-chemical profiles, in a nanoemulsion designed to be intraveinously administrable was explored. Nanoemulsions were spontaneously generated at room temperature by pouring a phosphate buffer in an anhydrous mixture containing pharmaceutically acceptable triglycerides and non-ionic surfactants. After determination of the apparent solubility of each API in excipients and characterization of mixtures by DSC, API-loaded nanoemulsions were formulated and characterized in terms of granulometric properties, surface potential, drug recovery efficiency, pH, osmolarity, in vitro drug release, and stability. Except ciprofloxacin, a BCS class IV drug, all studied APIs were soluble in at least one excipient used, i.e. Labrasol. At 2 wt% API, all drug-loaded nanoemulsions present properties compatible with i.v. administration. The formulation should permit to increase apparent solubility of poorly water-soluble APIs, and also to prolong delivery of hydrophobic as well of more hydrophilic compounds. Herein, the relative affinity of the API for nanodroplets and the release medium would directly influence drug release profiles. Nanoemulsions were stable for 7 days. They could also been extemporaneously reconstituted before use. Such a versatile nanoemulsion would provide a valuable option as formulation strategy for improvement of drug properties
Complete list of metadatas

https://hal-normandie-univ.archives-ouvertes.fr/hal-01847973
Contributor : Jocelyne Levillain <>
Submitted on : Tuesday, July 24, 2018 - 10:59:41 AM
Last modification on : Wednesday, January 6, 2021 - 11:20:29 AM

Identifiers

Citation

Emilie Gué, Marc Since, S. Ropars, R. Herbinet, L. Le Pluart, et al.. Evaluation of the versatile character of a nanoemulsion formulation. International Journal of Pharmaceutics, Elsevier, 2016, 498 (1-2), pp.49-65. ⟨10.1016/j.ijpharm.2015.12.010⟩. ⟨hal-01847973⟩

Share

Metrics

Record views

63